Analysts Are Highly Optimistic on Sanofi in March



Analysts’ recommendations and target price

Wall Street analysts have set Sanofi’s (SNY) 12-month consensus target price at $52, 15.79% higher than the stock’s closing price on March 18. Analysts’ consensus recommendation for the stock is a “strong buy.”

Analysts revised the stock’s target price upward from $51 in January to $52 in February, and they reiterated its $52 target price in March.

Of the four analysts covering Sanofi, three have given it “strong buy” recommendations, while the remaining analyst has given it a “hold.” The highest target price estimate for the company is $57, and the lowest is $48.

On March 18, Sanofi closed at $44.91, 0.40% lower than its previous closing price, 19.98% higher than its 52-week low of $37.43, and 1.56% lower than its 52-week high of $45.62. The company’s market cap is $110.30 billion.

Based on its closing price on March 18, Sanofi has reported returns of 3.29% in the last week, 8.06% in the last month, and 0.04% in the last quarter. The company has reported returns of 1.17% in the last half year, 10.75% in the last year, and 3.46% year-to-date.

Article continues below advertisement

Revenue and EPS estimates

Analysts expect Sanofi’s revenue to see YoY (year-over-year) changes of -2.78% to $9.43 billion in the first quarter, -3.30% to $9.42 billion in the second quarter, 0.36% to $10.96 billion in the third quarter, and 2.92% to $10.56 billion in the fourth quarter of 2019. Analysts also expect the company’s non-GAAP (generally accepted accounting principles) EPS to be $0.75 in the first quarter and see YoY changes of 1.35% to $0.75 in the second quarter, -6.54% to $1.00 in the third quarter, and 21.02% to $0.76 in the fourth quarter.

Analysts expect Sanofi’s revenue to see YoY rises of 0.13% to $40.70 billion in 2019, 3.08% to $41.96 billion in 2020, and 3.73% to $43.52 billion in 2021. Analysts also expect the company’s non-GAAP EPS to see YoY rises of 0.95% to $3.26 in 2019, 9.83% to $3.58 in 2020, and 9.04% to $3.90 in 2021.




More From Market Realist